Making top-quality cancer care accessible to all.100% free, no account required.

Measuring the Impact of CBD on Joint Pain in Women With Breast Cancer

NCT06538389 · Recruiting
About this trial

This trial studies how well a CBD plant extract can improve joint pain and stiffness in women with breast cancer taking aromatase inhibitors (AIs). Aromatase inhibitors help lower estrogen levels to reduce the chance of breast cancer coming back. However, some women experience joint issues as a side effect, which can lead them to stop taking AIs. This study aims to see if CBD can help reduce that pain and improve comfort.

Locations and contact

This trial is running at 1 location in the United States. It is currently recruiting.

United States1 location · 1 recruiting
  • City of Hope Medical CenterDuarte, CaliforniaRecruiting
Who to ask about joining
Who can join

Women aged 18 and older can join if they are postmenopausal and have breast cancer that is hormone-sensitive. They should be taking aromatase inhibitors for at least 90 days and plan to continue for at least 180 days. The trial team will confirm eligibility, so not everyone may qualify.

What happens during the trial

Participants will be randomly placed into one of two groups. One group will receive the CBD extract twice daily for up to three months. The other group will receive a placebo (a fake treatment) also twice daily for the same time. Both groups will have blood samples taken during the study.

The trial team

The trial is sponsored by City of Hope Medical Center, with collaboration from the National Cancer Institute and Biopharmaceutical Research Company. Dr. Lisa D Yee is the principal investigator leading the study.

Important dates

The trial started on August 26, 2024, and is expected to finish by January 24, 2027. It is currently enrolling new participants.

Additional information

The trial's ID number is NCT06538389. This is a Phase 2 trial, which means it is looking at how well the treatment works and how safe it is. It is regulated by the FDA and aims to include 36 participants.

Similar trials

Other recruiting trials for the same condition, with the eligibility rules written in plain language.

Browse similar trials
Talk to a specialist

Find a top oncologist who can tell you whether a trial is a sensible option for you.

Find a doctor
Cancer hospitals

The cancer centers running studies like this one, and what each is known for.

Browse hospitals